Searchable abstracts of presentations at key conferences in endocrinology

ea0047oc18 | Spotlight on Prostate Cancer | Theranostics2016

The Holy Grail: individualised dosimetry for radionuclide therapy

Bailey Dale

Historically, many radionuclide therapy (RNT) procedures practiced in nuclear medicine have employed standardised amounts of a radionuclide for the therapy. This often neglects factors such as patient size, tumour burden, rate of disease progression and intra-lesional heterogeneity. At the opposite end of the spectrum, treatment procedures using external beam radiotherapy (EBRT) have become increasingly individualised to maximise the dose to target whilst minimising radiation ...